Immuneonco Biopharmaceuticals (shanghai) Inc.

This phase 3 trial tests whether adding the experimental drug IMM01 to standard chemotherapy (azacitidine) helps people with newly diagnosed chronic myelomonocytic leukemia (CMML). About 170 adults will be randomly assigned to get either the combo or a placebo plus chemotherapy. …

This early-stage study tests an injectable drug called IMC-001 in 18 people who recently had a heart attack or unstable angina. The goal is to see if it can make fatty plaques in the arteries more stable and less likely to cause future problems. Participants receive either the dr…

This early-stage study tests the safety of an experimental drug called IMC-003 in healthy postmenopausal women aged 45 to 75. Participants receive either the drug or a placebo, and researchers monitor side effects and how the drug moves through the body. The goal is to gather saf…